Pfizer Articles
Wyeth donates $100K to ASCO Cancer Foundation
1 June 2009
Gov't of Venezuela may buy Pfizer facility
1 June 2009
Wyeth presents strong combo drug data at ASCO
29 May 2009
Pfizer to raise $10.6B to finance Wyeth buy
28 May 2009
Retail drug sales in year to March 2009
22 May 2009
Pfizer
21 May 2009
Stock Commentary - New York week to May 18, 2009
21 May 2009
Sutent recommended as UK 1st-line mRCC drug
18 May 2009
Endo names Alan Levin CFO
14 May 2009
Pfizer offers free drugs to recently unemployed
14 May 2009
UPDATE: Ligand's 1st-qtr 2009 loss deepens 30%
12 May 2009
Ligand narrows loss on rocketing revenue
8 May 2009
Pfizer names Freda Lewis-Hall as CMO
7 May 2009
Vertex promotes Peter Mueller to EVP of R&D
7 May 2009
Kinaxo discovers new target for Pfizer's Celebrex
30 April 2009
Wyeth's first-quarter 2009 profit flat year-on-year as it prepares for Pfizer mega-merger
29 April 2009
Pfizer's "fake drug" ads did not breach code
29 April 2009
Wyeth's Conbriza approved in Europe
28 April 2009
"Perverse" NICE again says "No" to new drugs
28 April 2009
URCH study foresees more pharma mega-mergers
27 April 2009
Pfizer well-positioned for Wyeth merger
24 April 2009
CHMP meeting sees good news for AZ, but not for Teva
24 April 2009
Pfizer buys into stem cell research for AMD
24 April 2009
Retail drug sales in year to February 2009
24 April 2009
Novartis' 1st-qtr 2009 results boosted by new products
24 April 2009
Drugmakers spent $3M in Vermont
21 April 2009
GSK to buy US derma co Steifel for $2.9B+
20 April 2009
Pfizer appoints Martine George as VP of medical affairs
16 April 2009
GSK and Pfizer pool HIV/AIDS assets in JV
16 April 2009
Medivation/Pfizer initiate Ph III Dimebon trial
15 April 2009
AZ eyeing up small European firms
15 April 2009
No eye damage link for Viagra/Cialis; study
15 April 2009
Wyeth provides limited update
14 April 2009
SCLC drug market wil more than double to $648M in 2017
14 April 2009
DDMAC hits sponsored Internet drug links
14 April 2009
US Lipitor and Lexapro cost cut by pill splitting
14 April 2009
Pfizer increases Indian subsidiary investment
14 April 2009
Daiichi/Lilly's Efient gets first world launch in UK - first new antiplatelet drug in a decade
9 April 2009
CyDex Pharma IP to be auctioned
8 April 2009
Pfizer announces Wyeth execs it plans to retain
8 April 2009
FTC calls for more info on Pfizer/Wyeth deal
8 April 2009
Stock Commentary - New York week to Aug 15
8 April 2009
French pharmacy sales up only 1.8% in 2008
6 April 2009
Pfizer's R&D pipeline down 12% on six months ago as part of new focus high-priority areas
3 April 2009
Belgium's govt R&D summit convened
3 April 2009
Retail drug sales in year to January 2009
3 April 2009
Afinitor cleared in USA for advanced RCC
1 April 2009
NexGen founder's patent improves chemo
30 March 2009
US drug sales growth slows to 1.3%
30 March 2009
Pfizer completes $13.5M debt offering
30 March 2009
Sutent cleared for UK kidney cancer patients
30 March 2009
Retail drug sales in year to December 2008
30 March 2009
Lyrica fares well vs venlafaxine-ER in GAD
30 March 2009
Cilengitide "promotes cancer growth"
30 March 2009
Impax to co-promote Wyeth's Pristiq
30 March 2009
XOMA in trouble as 2008 loss rockets
30 March 2009
Pfizer centers regional ops in Costa Rica
30 March 2009
Study shows no higher cancer risk with Vytorin
27 March 2009
Mylan group sued over for first-to-file ANDAs
27 March 2009
Pfizer sells bonds to cover Wyeth debts
23 March 2009
NicOx enters Ph I with Lipitor competitor
23 March 2009
Data on withdrawn drugs was faked; says hospital
16 March 2009
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
